Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2023

Aug 10, 2023

SELL
$100.78 - $112.29 $23,078 - $25,714
-229 Reduced 4.4%
4,978 $542,000
Q1 2023

Apr 24, 2023

SELL
$96.86 - $114.01 $26,733 - $31,466
-276 Reduced 5.03%
5,207 $527,000
Q4 2022

Jan 26, 2023

SELL
$95.06 - $111.52 $88,310 - $103,602
-929 Reduced 14.49%
5,483 $0
Q3 2022

Oct 14, 2022

SELL
$96.76 - $112.03 $25,931 - $30,024
-268 Reduced 4.01%
6,412 $620,000
Q2 2022

Jul 22, 2022

SELL
$102.07 - $123.37 $117,482 - $141,998
-1,151 Reduced 14.7%
6,680 $725,000
Q1 2022

May 06, 2022

SELL
$114.02 - $139.04 $38,538 - $46,995
-338 Reduced 4.14%
7,831 $926,000
Q4 2021

Feb 08, 2022

BUY
$115.53 - $141.46 $943,764 - $1.16 Million
8,169 New
8,169 $1.15 Million

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $208B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Granite Shares Advisors LLC Portfolio

Follow Granite Shares Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Granite Shares Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Granite Shares Advisors LLC with notifications on news.